Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China Study
一项针对既往未接受治疗的PD-L1阳性局部晚期或转移性非小细胞肺癌中国患者的帕博利珠单抗与化疗的随机临床试验：KEYNOTE-042中国研究
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.33399
Wu, Yi-Long; Zhang, Li; Fan, Yun; Zhou, JianYing; Zhang, Li; Zhou, Qing; Li, Wei; Hu, ChengPing; Chen, GongYan; Zhang, Xin; Zhou, CaiCun; Dang, Thao; Sadowski, Sara; Kush, Debra A; Zhou, Yu; Li, Ben; Mok, Tony
